Federal Register of Legislation - Australian Government

Primary content


This gazette
— p 3052
Section 14 and 14A Notice
Administered by: Health
Published Date 21 Nov 2012
Printed Publication Date 21 Nov 2012



I, MAYADA KAYALI, delegate of the Secretary to the Department of Health and Ageing for the purposes of sections 14, 14A and 15 of the Therapeutic Goods Act 1989 (‘the Act’) hereby give my consent, pursuant to sections 14 and 14A of the Act, for Pfizer Australia Pty Ltd of Unit 21B, 1 Maitland Place, Norwest Business Park, Baulkham Hills NSW 2153, to supply three batches of DIMETAPP DAYTIME/NIGHTIME LIQUID CAPS capsule blister pack (AUST R 137255) – ie. batch numbers C8787A, C8787B and C8779 – that do not comply with Therapeutic Goods Order No. 69 – General Requirements for Labelling for Medicines such that the blister packs include the name of the previous sponsor (Wyeth) of the product and not the current sponsor (Pfizer). 


Pursuant to section 15(1) of the Act, my consent is subject to the following condition:


1.       The product complies with all other aspects of the standard.





(Signed by)



Mayada Kayali

Delegate of the Secretary

Office of Medicines Authorisation


14  November 2012